V45I (p.Val45Ile) variant of CASQ2 (Calsequestrin-2)

V45I (p.Val45Ile) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

V45I (p.Val45Ile) variant details